Previous Close | 1.1400 |
Open | 1.1300 |
Bid | 1.1100 x 400 |
Ask | 1.1700 x 200 |
Day's Range | 1.1100 - 1.1560 |
52 Week Range | 0.7100 - 1.9600 |
Volume | |
Avg. Volume | 1,351,509 |
Market Cap | 197.331M |
Beta (5Y Monthly) | 0.98 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Key Financial Highlights from Rigel's Earnings Report
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript March 5, 2024 Rigel Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2023. […]